Stay updated on Apatinib Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.

Latest updates to the Apatinib Plus Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to the study details or page content.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedUpdated the site revision to v3.4.2 and removed the government funding status notice that accompanied v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check61 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center status was added, and the site revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check68 days agoChange DetectedThe page now includes a glossary toggle, changes the QC update label to 'Last Update Submitted that Met QC Criteria' (from 'Last Update Submitted that met QC Criteria'), standardizes 'No FEAR Act Data' capitalization, and updates the revision footer from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check82 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Apatinib Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.